Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

56 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Epidermolysis-Bullosa-Associated Squamous Cell Carcinomas Support an Immunosuppressive Tumor Microenvironment: Prospects for Immunotherapy.
Rafei-Shamsabadi D, Scholten L, Lu S, Castiglia D, Zambruno G, Volz A, Arnold A, Saleva M, Martin L, Technau-Hafsi K, Meiss F, von Bubnoff D, Has C. Rafei-Shamsabadi D, et al. Among authors: von bubnoff d. Cancers (Basel). 2024 Jan 22;16(2):471. doi: 10.3390/cancers16020471. Cancers (Basel). 2024. PMID: 38275911 Free PMC article.
Indoleamine 2,3-Dioxygenase Expression in Primary Cutaneous Melanoma Correlates with Breslow Thickness and Is of Significant Prognostic Value for Progression-Free Survival.
Rubel F, Kern JS, Technau-Hafsi K, Uhrich S, Thoma K, Häcker G, von Bubnoff N, Meiss F, von Bubnoff D. Rubel F, et al. Among authors: von bubnoff d, von bubnoff n. J Invest Dermatol. 2018 Mar;138(3):679-687. doi: 10.1016/j.jid.2017.09.036. Epub 2017 Oct 18. J Invest Dermatol. 2018. PMID: 29054599 Free article.
Successful combination therapy of systemic checkpoint inhibitors and intralesional interleukin-2 in patients with metastatic melanoma with primary therapeutic resistance to checkpoint inhibitors alone.
Rafei-Shamsabadi D, Lehr S, von Bubnoff D, Meiss F. Rafei-Shamsabadi D, et al. Among authors: von bubnoff d. Cancer Immunol Immunother. 2019 Sep;68(9):1417-1428. doi: 10.1007/s00262-019-02377-x. Epub 2019 Aug 17. Cancer Immunol Immunother. 2019. PMID: 31422446 Free PMC article.
56 results